| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $371.0M | — | +22.6% |
| Cost of Revenue | $281.4M | — | +22.9% |
| Gross Profit | $89.6M | — | +21.7% |
| R&D Expense | $10.7M | — | +7.0% |
| SG&A Expense | $72.3M | — | +26.8% |
| Operating Income | $4.7M | — | -28.8% |
| Pre-tax Income | $9.8M | — | +81.5% |
| Income Tax | -$2.1M | — | -333.3% |
| Net Income | $11.9M | — | +164.4% |
| EPS (Basic) | $0.07 | — | +133.3% |
| EPS (Diluted) | $0.07 | — | +133.3% |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.46B | +161.2% | +455.3% |
| Accounts Receivable | $194.5M | +17.9% | +64.6% |
| Current Assets | $2.31B | +82.9% | +167.3% |
| Total Assets | $4.04B | +63.9% | +101.6% |
| Current Liabilities | $410.7M | +32.1% | +34.7% |
| Total Liabilities | $632.7M |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$27.4M | — | +6.2% |
| Investing Cash Flow | -$365.1M | — | -1515.5% |
| Financing Cash Flow | $1.30B | — | +9046.9% |
| +2.5% |
| Stockholders' Equity | $3.41B | +70.8% | +145.7% |